Evidence map›Paper›PMID 40525497›Full record

ArticleClinical genetics2025

Genetic and Structural Variations in Czech Patients With Congenital Myopathies.

Jana Zídková, Barbora Lauerová, Lívie Mensová, Tereza Kramářová, Johana Kopčilová, Kamila Réblová, Magdaléna Soukup Vodičková, Martina Hujňáková, Jana Haberlová, Marie Rohlenová and 17 more

Abstract read
In one paragraph

Article in Clinical genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Jana ZídkováCentre of Molecular Biology and Genetics, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Barbora LauerováDepartment of Paediatric Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Praha, Czech Republic.
Lívie MensováDepartment of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Praha, Czech Republic.
Tereza KramářováCentre of Molecular Biology and Genetics, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Johana KopčilováCentre of Molecular Biology and Genetics, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Kamila RéblováCentre of Molecular Biology and Genetics, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Magdaléna Soukup VodičkováCentre of Molecular Biology and Genetics, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Martina HujňákováCentre of Molecular Biology and Genetics, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Jana HaberlováDepartment of Paediatric Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Praha, Czech Republic.
Marie RohlenováDepartment of Paediatric Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Praha, Czech Republic.
Radim MazanecDepartment of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Praha, Czech Republic.
Jana ŠoukalováInstitute of Medical Genetics and Genomics, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Renata GaillyováInstitute of Medical Genetics and Genomics, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Emílie VyhnálkováDepartment of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Miroslava BalaščakováDepartment of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Pavlína DanhoferDepartment of Child Neurology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Lenka JuříkováDepartment of Child Neurology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Dagmar GrečmalováInstitute of Clinical and Molecular Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic.
Andrea GřegořováInstitute of Clinical and Molecular Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic.
Pavlína PlevováInstitute of Clinical and Molecular Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic.
Martina LangováDepartment of Medical Genetics, Thomayer University Hospital, Praha, Czech Republic.
Tomáš HonzíkDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Praha, Czech Republic.
Martin MagnerDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Praha, Czech Republic.
Martina KlincováDepartment of Pediatric Anesthesiology and Intensive Care Medicine, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Pavla SolařováDepartment of Medical Genetics, University Hospital Hradec Králové, Hradec Králové, Czech Republic.
Mária ŠenkeříkováDepartment of Medical Genetics, University Hospital Hradec Králové, Hradec Králové, Czech Republic.
Lenka FajkusováCentre of Molecular Biology and Genetics, University Hospital Brno and Masaryk University, Brno, Czech Republic.

Funding

Czech Health Research Council (AZV ČR) NU21-06- 00363Ministry of Health, Czech Republic - conceptual development of research organization 65269705Ministry of Health, Czech Republic - conceptual development of research organization FNBr
6 · The paper itself

Abstract

Congenital myopathies (CMs) are a heterogeneous group of genetic muscle disorders characterized by hypotonia and muscle weakness, with pathogenic variants identified in at least 41 genes and inheritance patterns including autosomal dominant (AD), recessive (AR), and X-linked (XL). We present 79 unrelated patients with genetically confirmed CM using next-generation sequencing (NGS). A total of 113 mutant alleles carrying 97 different variants with a presumed pathogenic effect were identified. According to the HGMD database, 54 of these variants have been reported exclusively in the Czech CM population to date. All but five variants were small-scale. Large gene deletions were identified in the MTM1, NEB, and RYR1 genes. Sequencing of breakpoint junctions in the identified NEB and RYR1 deletions provided insights into the upstream mechanisms leading to genomic instability and resulting in structural variations. We present the family with dominant inheritance of the NEB deletion of exons 19-78. We assume that our family represents another reported case of a dominant mutation in the NEB gene. Our results contribute to further knowledge in the field of neuromuscular diseases and mutational mechanisms.

Indexed as

Genetic Predisposition to DiseaseMuscle ProteinsMyopathies, Structural, CongenitalAdultChildChild, PreschoolCzech RepublicFemaleHigh-Throughput Nucleotide SequencingHumansMaleMutationPedigreeRyanodine Receptor Calcium Release ChannelMuscle ProteinsnebulinRyanodine Receptor Calcium Release ChannelRYR1 protein, humanbreakpoint analysiscongenital myopathydeletionstructural variants

Identifiers

PMID40525497
PMCPMC12580487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.